New Delhi: Drug firm Unichem Laboratories today reported a 11.28 per cent dip in standalone net profit to Rs 20.52 crore for the second quarter ended September 30, 2016.
The company had posted a net profit of Rs 23.13 crore for the corresponding period of the previous fiscal, Unichem Laboratories said in a filing to BSE.
Standalone total income from operations of the company, however, rose to Rs 368.03 crore for the quarter under consideration as against Rs 309.79 crore for the same period year-ago.
Unichem manufactures and markets pharmaceutical formulations in India and several other markets across the world.
Shares of Unichem Laboratories were today trading at Rs 280.90 per scrip in the afternoon trade on BSE, down 7.70 per cent from its previous close.
New Delhi: Drug firm Unichem Laboratories today reported a 11.28 per cent dip in standalone net profit to Rs 20.52 crore for the second quarter ended September 30, 2016.
The company had posted a net profit of Rs 23.13 crore for the corresponding period of the previous fiscal, Unichem Laboratories said in a filing to BSE.
Standalone total income from operations of the company, however, rose to Rs 368.03 crore for the quarter under consideration as against Rs 309.79 crore for the same period year-ago.
Unichem manufactures and markets pharmaceutical formulations in India and several other markets across the world.
Shares of Unichem Laboratories were today trading at Rs 280.90 per scrip in the afternoon trade on BSE, down 7.70 per cent from its previous close.
New Delhi: Drug firm Unichem Laboratories today reported a 11.28 per cent dip in standalone net profit to Rs 20.52 crore for the second quarter ended September 30, 2016.
The company had posted a net profit of Rs 23.13 crore for the corresponding period of the previous fiscal, Unichem Laboratories said in a filing to BSE.
Standalone total income from operations of the company, however, rose to Rs 368.03 crore for the quarter under consideration as against Rs 309.79 crore for the same period year-ago.
Unichem manufactures and markets pharmaceutical formulations in India and several other markets across the world.
Shares of Unichem Laboratories were today trading at Rs 280.90 per scrip in the afternoon trade on BSE, down 7.70 per cent from its previous close.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
Sign Up with Google
RECOMMENDED FOR YOU
POPULAR